Omega Therapeutics, Inc.
OMGAQ
$0.055
$0.0122.22%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -73.09M | -78.90M | -92.28M | -97.43M | -108.04M |
| Total Depreciation and Amortization | 7.31M | 6.07M | 7.28M | 6.77M | 6.31M |
| Total Amortization of Deferred Charges | 55.00K | 57.00K | 56.00K | 53.00K | 67.00K |
| Total Other Non-Cash Items | 8.50M | 9.06M | 9.57M | 8.46M | 8.62M |
| Change in Net Operating Assets | 1.65M | -899.00K | 169.00K | -9.37M | -5.61M |
| Cash from Operations | -55.58M | -64.60M | -75.20M | -91.51M | -98.66M |
| Capital Expenditure | -2.06M | -2.77M | -3.40M | -2.87M | -2.05M |
| Sale of Property, Plant, and Equipment | 650.00K | 650.00K | 650.00K | 650.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.60M | 7.60M | 32.68M | 49.73M | 65.08M |
| Cash from Investing | 6.19M | 5.49M | 29.93M | 47.52M | 63.03M |
| Total Debt Issued | 2.62M | 2.62M | 2.62M | 2.62M | -- |
| Total Debt Repaid | -4.65M | -3.21M | -2.09M | -1.00M | -- |
| Issuance of Common Stock | 26.00K | 31.00K | 402.00K | 40.49M | 41.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -15.00K | -167.00K | -288.00K | -288.00K |
| Cash from Financing | -2.00M | -566.00K | 766.00K | 41.82M | 40.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.39M | -59.69M | -44.51M | -2.17M | 5.15M |